Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2

PHASE3CompletedINTERVENTIONAL
Enrollment

615

Participants

Timeline

Start Date

January 21, 2013

Primary Completion Date

October 10, 2013

Study Completion Date

October 29, 2013

Conditions
Hyperlipidemia
Interventions
BIOLOGICAL

Evolocumab

Administered by subcutaneous injection

DRUG

Ezetimibe

Administered orally once a day

BIOLOGICAL

Placebo to Evolocumab

Administered by subcutaneous injection

OTHER

Placebo to Ezetimibe

Administered orally once daily

Trial Locations (83)

100

Research Site, Taipei

807

Research Site, Kaohsiung City

1080

Research Site, Brussels

1449

Research Site, Alberton

1630

Research Site, Linkebeek

2010

Research Site, Darlinghurst

2035

Research Site, Maroubra

2196

Research Site, Johannesburg

2470

Research Site, Retie

2750

Research Site, Ballerup Municipality

3545

Research Site, Halen

3945

Research Site, Ham

3980

Research Site, Tessenderlo

4075

Research Site, Sherwood

4152

Research Site, Carina Heights

5520

Research Site, Anthée

6534

Research Site, Gozée

6850

Research Site, Worcester

6887

Research Site, Gribomont

7100

Research Site, Vejle

7130

Research Site, Somerset West

7505

Research Site, Parow

9000

Research Site, Aalborg

9301

Research Site, Bloemfontein

12553

Research Site, New Windsor

13760

Research Site, Endwell

16635

Research Site, Duncansville

20817

Research Site, Bethesda

23294

Research Site, Richmond

23502

Research Site, Norfolk

27609

Research Site, Raleigh

27612

Research Site, Raleigh

29464

Research Site, Mt. Pleasant

29621

Research Site, Anderson

32081

Research Site, Ponte Vedra

32204

Research Site, Jacksonville

32216

Research Site, Jacksonville

32771

Research Site, Sanford

33144

Research Site, Miami

34093

Research Site, Istanbul

34662

Research Site, Istanbul

35216

Research Site, Birmingham

38043

Research Site, Grenoble

38305

Research Site, Jackson

38610

Research Site, Gières

38654

Research Site, Olive Branch

40213

Research Site, Louisville

44122

Research Site, Cleveland

44311

Research Site, Akron

45212

Research Site, Cincinnati

45236

Research Site, Cincinnati

45246

Research Site, Cincinnati

46260

Research Site, Indianapolis

55435

Research Site, Edina

57702

Research Site, Rapid City

58103

Research Site, Fargo

60654

Research Site, Chicago

66202

Research Site, Overland Park

72205

Research Site, Little Rock

73069

Research Site, Norman

73103

Research Site, Oklahoma City

75230

Research Site, Dallas

78006

Research Site, Boerne

78205

Research Site, San Antonio

83301

Research Site, Kaohsiung City

83704

Research Site, Boise

84124

Research Site, Salt Lake City

85224

Research Site, Chandler

89148

Research Site, Las Vegas

92024

Research Site, Encinitas

92111

Research Site, San Diego

92780

Research Site, Tustin

95608

Research Site, Carmichael

98057

Research Site, Renton

98104

Research Site, Seattle

02301

Research Site, Brockton

A0A 1G0

Research Site, Bay Roberts

A1N 1W7

Research Site, Mount Pearl

M9W 4L6

Research Site, Toronto

J2G 8Z9

Research Site, Granby

120-752

Research Site, Seoul

135-710

Research Site, Seoul

138-736

Research Site, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY